GGrantIndex
Sort

51,593 grants matching hepatitis

Investigation of ACAT Functions Using Knockout

$529,274
J. David Gladstone Institutes · R01 · FY2005 · HL

Intravenous delivery of 2-hydroxypropyl-Beta-cyclodextrin for treatment of Niemann-Pick C disease

$529,267
Daniel S Ory · Washington University · U01 · FY2017 · HD

Insulin Resistance in Vascular Endothelial Cells and Foxo

$529,258
Domenico Accili · Columbia University Health Sciences · P01 · FY2014 · HL

Mechanisms for gestational hypoxia reprogramming of adipose

$529,176
Charles A Ducsay · Loma Linda University · P01 · FY2020 · HD

Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis

$529,110
Jennifer Y. Chen · University Of California, San Francisco · R01 · FY2023 · DK

Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD

$529,108
Jennifer R Havens · University Of Kentucky · R01 · FY2020 · DA

Defining a Protective Ebola Vaccine in Non-Human Primates

$529,083
Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2017 · AI

Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol

$529,043
Larisa Y Poluektova · University Of Nebraska Medical Center · R01 · FY2019 · AA

DEVELOPMENT OF THE HBcAG AS A VACCINE CARRIER PLATFORM

$528,945
David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2007 · AI

The Lipin Protein Family and Triglyceride Metabolism

$528,938
Karen Reue · University Of California Los Angeles · P01 · FY2015 · HL

Viruses and Hematopoiesis

$528,904
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

Metabolic Crosstalk During Hepatic Insulin Resistance

$528,840
Morris F. White · Boston Children'S Hospital · R01 · FY2020 · DK

Virtual and Augmented Reality Guidance for Hepatic RFA

$528,631
Henry Fuchs · Univ Of North Carolina Chapel Hill · R01 · FY2006 · CA

Mid Southern Primary Care Networks Node

$528,610
Li-Tzy T Wu · Duke University · UG1 · FY2018 · DA

See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization Drug Delivery

$528,511
Jean-Francois H Geschwind · Johns Hopkins University · R01 · FY2012 · CA

CBPR on Hepatitis B Intervention for Underserved Korean Americans

$528,453
Grace X Ma · Temple Univ Of The Commonwealth · R24 · FY2008 · MD

Circadian SCN-Liver Axis in the Neuroendocrine Response to Calorie Restriction

$528,389
Joseph T Bass · Northwestern University At Chicago · R01 · FY2025 · DK

Circadian SCN-Liver Axis in the Neuroendocrine Response to Calorie Restriction

$528,389
Joseph T Bass · Northwestern University At Chicago · R01 · FY2023 · DK

Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry

$528,379
Joshua D Lee · New York University School Of Medicine · U01 · FY2017 · DA

Genetic Analysis of Molecular Interactions in Coronavirus Replication

$528,375
Paul Scott Masters · Wadsworth Center · R01 · FY2013 · AI

Predicting Brain Changes in HIV/AIDS

$528,366
Paul M Thompson · University Of Southern California · R01 · FY2015 · NS

Immune suppressor mechanism in a murine model of hepatitis and liver cancer

$528,324
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin Resistance

$528,322
Edward A Fisher · New York University School Of Medicine · P01 · FY2024 · HL

Critical Lipid Species in the Hepatovirus Lifecycle

$528,265
Stanley M Lemon · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI

MAF1 Function and Metabolic Inefficiency

$528,171
Ian M Willis · Albert Einstein College Of Medicine · R01 · FY2019 · GM